Skip Nav Destination
Close Modal
Update search
Filter
All
- All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
All
- All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
All
- All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
All
- All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
All
- All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
All
- All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
NARROW
Format
Subjects
Journal
Article Type
Date
Availability
1-2 of 2
Keywords: Infusion, continuous
Close
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Sort by
Journal Articles
Paclitaxel by 72-Hour Continuous Infusion Followed by Bolus Intravenous Ifosfamide or Epirubicin: Results of Two Phase I Studies
Available to PurchaseSubject Area:
Oncology
Journal:
Oncology
Oncology (2001) 60 (2): 116–122.
Published Online: 23 February 2001
... to in the content or advertisements. Phase I Paclitaxel Infusion, continuous Ifosfamide Epirubicin Paclitaxel, the first approved member of the taxane class of cytotoxic agents, has broad antitumor activity and is effective against several malignancies that respond poorly to other agents...
Journal Articles
Activity of Gemcitabine and Continuous Infusion Fluorouracil in Advanced Pancreatic Cancer
Available to PurchaseSubject Area:
Oncology
Journal:
Oncology
Oncology (2000) 60 (1): 43–48.
Published Online: 28 December 2000
... weeks out of every 4 weeks. This trial assessed efficacy, toxicity, and impact on quality of life parameters of gemcitabine in combination with CI fluorouracil in chemotherapy-naïve, advanced pancreatic cancer patients. 28 12 2000 Gemcitabine Fluorouracil Infusion, continuous Phase...
